R
Remed Co Ltd
KOSDAQ:302550
Remed Co Ltd
KOSDAQ:302550
Price:
3 145
KRW
1.45%
Market Closed
Market Cap:
₩99.1B
Income Statement
Earnings Waterfall
Remed Co Ltd
Remed Co Ltd
Income Statement
Remed Co Ltd
Remed Co Ltd
Currency: KRW
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
909
|
798
|
845
|
967
|
1 085
|
1 216
|
1 244
|
830
|
794
|
1 119
|
1 174
|
1 152
|
1 086
|
974
|
|
| Revenue |
21 484
N/A
|
21 223
-1%
|
22 833
+8%
|
21 363
-6%
|
21 646
+1%
|
21 510
-1%
|
18 536
-14%
|
14 553
-21%
|
17 389
+19%
|
23 423
+35%
|
25 554
+9%
|
26 681
+4%
|
24 478
-8%
|
24 256
-1%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(10 270)
|
(9 638)
|
(10 458)
|
(10 171)
|
(10 371)
|
(10 828)
|
(9 503)
|
(7 474)
|
(8 300)
|
(10 958)
|
(11 380)
|
(11 455)
|
(10 230)
|
(9 869)
|
|
| Gross Profit |
11 213
N/A
|
11 584
+3%
|
12 376
+7%
|
11 193
-10%
|
11 275
+1%
|
10 682
-5%
|
9 033
-15%
|
7 079
-22%
|
9 088
+28%
|
12 465
+37%
|
14 174
+14%
|
15 226
+7%
|
14 249
-6%
|
14 387
+1%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(9 581)
|
(9 914)
|
(9 955)
|
(9 532)
|
(9 908)
|
(10 490)
|
(11 893)
|
(7 665)
|
(7 375)
|
(10 627)
|
(13 053)
|
(13 812)
|
(14 241)
|
(13 962)
|
|
| Selling, General & Administrative |
(6 483)
|
(6 810)
|
(6 797)
|
(6 620)
|
(7 007)
|
(7 290)
|
(8 287)
|
(6 069)
|
(5 691)
|
(7 992)
|
(8 628)
|
(8 906)
|
(9 346)
|
(9 258)
|
|
| Research & Development |
(2 770)
|
(2 712)
|
(2 722)
|
(2 426)
|
(2 373)
|
(2 628)
|
(2 940)
|
(2 406)
|
(2 417)
|
(3 132)
|
(3 483)
|
(3 685)
|
(3 661)
|
(3 720)
|
|
| Depreciation & Amortization |
(352)
|
(392)
|
(435)
|
(486)
|
(528)
|
(572)
|
(666)
|
(574)
|
(663)
|
(898)
|
(941)
|
(963)
|
(966)
|
(984)
|
|
| Other Operating Expenses |
24
|
0
|
0
|
0
|
0
|
0
|
0
|
1 385
|
1 395
|
1 395
|
0
|
(258)
|
(269)
|
0
|
|
| Operating Income |
1 632
N/A
|
1 670
+2%
|
2 421
+45%
|
1 661
-31%
|
1 366
-18%
|
192
-86%
|
(2 860)
N/A
|
(586)
+80%
|
1 714
N/A
|
1 838
+7%
|
1 121
-39%
|
1 414
+26%
|
7
-99%
|
424
+5 601%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(776)
|
1 043
|
1 492
|
2 625
|
2 741
|
(1 005)
|
(446)
|
(556)
|
(1 456)
|
(1 890)
|
1 927
|
1 734
|
2 511
|
2 938
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
3 992
|
0
|
0
|
0
|
(269)
|
0
|
0
|
(299)
|
|
| Gain/Loss on Disposition of Assets |
0
|
(78)
|
(83)
|
(71)
|
(71)
|
(7)
|
(0)
|
(0)
|
288
|
4 400
|
4 400
|
0
|
0
|
(93)
|
|
| Total Other Income |
377
|
230
|
326
|
344
|
375
|
366
|
294
|
213
|
674
|
704
|
866
|
5 246
|
4 495
|
390
|
|
| Pre-Tax Income |
1 234
N/A
|
2 865
+132%
|
4 155
+45%
|
4 560
+10%
|
4 411
-3%
|
(453)
N/A
|
980
N/A
|
(929)
N/A
|
1 219
N/A
|
5 052
+315%
|
8 045
+59%
|
8 394
+4%
|
7 014
-16%
|
3 360
-52%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
21
|
(258)
|
(337)
|
(609)
|
(871)
|
121
|
(660)
|
(87)
|
(293)
|
(683)
|
(665)
|
(646)
|
(455)
|
(78)
|
|
| Income from Continuing Operations |
1 255
|
2 608
|
3 819
|
3 951
|
3 540
|
(332)
|
319
|
(1 016)
|
925
|
4 369
|
7 381
|
7 748
|
6 559
|
3 283
|
|
| Income to Minority Interest |
0
|
0
|
0
|
49
|
122
|
245
|
478
|
319
|
294
|
494
|
(209)
|
(38)
|
(82)
|
(5)
|
|
| Net Income (Common) |
1 255
N/A
|
2 608
+108%
|
3 819
+46%
|
4 000
+5%
|
3 662
-8%
|
(88)
N/A
|
797
N/A
|
(697)
N/A
|
1 219
N/A
|
4 863
+299%
|
7 172
+47%
|
7 710
+8%
|
6 477
-16%
|
3 278
-49%
|
|
| EPS (Diluted) |
204.84
N/A
|
343.01
+67%
|
477.69
+39%
|
105.24
-78%
|
597.64
+468%
|
-14.28
N/A
|
26.02
N/A
|
-22.76
N/A
|
39.79
N/A
|
145.18
+265%
|
214.11
+47%
|
251.64
+18%
|
210.68
-16%
|
103.1
-51%
|
|
Switch to:
Switch to:
See Also
Discover More
